Log into the BADBIR Database for clinicians

This is the clinical research system for managing BADBIR patients, follow-ups, and study documentation.

Password

If you're used to logging into our old system, please now use the email address associated with your account, instead of your old username.

Email us if you need to change your email address.

Forgot password

BADBIR News

Our database has undergone a major update! We expect some minor teething issues, please let us know by using the Report an issue button at the top of every page if you spot anything that doesn't work.

1/6 Recruitment for Cosentyx (secukinumab) and Spevigo (spesolimab) ended on 1 August 2026 - please enter any eligible participants onto the database by 21 August
2/6 BADBIR will be attending the BDNG Conference from 13 October 2026 for the full three-day event
3/6 Recruitment for patients commencing Sotyktu (deucravicitinib) ended on 20th May 2026
4/6 Read more: Changes to conventional cohort eligibility criteria
5/6 Our new 2026 Annual Update is now available to read
6/6 Patients diagnosed with Generalised Pustular Psoriasis are eligible on Spevigo (spesolimab) or conventional treatment

Find out more on our website.

Are you a participant?

If you're a patient registered with the BADBIR study, you have a separate login here: BADBIR Patient Portal.